Good evening :)
$
₹
Evolent Health Inc

Evolent Health Inc

EVH

NYSE
Asset Logo

Evolent Health Inc

EVH

NYSE
$4.540.11% (+0.00)
$
₹
$4.540.11% (+0.00)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Health Information Services

Small Cap

With a market cap of $542.7M the stock is ranked 3306

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

1.26
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-4.49
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

1.92
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

-24.08%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 14 analysts reports

Buy
11 analysts
Hold
3 analysts
Sell
0 analyst

Price Upside

+19.79%

Earnings Growth

+899.5%

Rev. Growth

+40.46%

See Detailed Forecast

Company Profile

Company Profile

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
Veeva Systems Inc Class A
VEEV
Veeva Systems Inc Class A
P/E Ratio
50.92
50.92
1Y Return
5.02%
5.02%
Buy Reco %
68.96
68.96
Doximity Inc
DOCS
Doximity Inc
P/E Ratio
40.78
40.78
1Y Return
45.81%
45.81%
Buy Reco %
38.09
38.09
Waystar Holding Corp. Common Stock
WAY
Waystar Holding Corp. Common Stock
P/E Ratio
40.12
40.12
1Y Return
21.41%
21.41%
Buy Reco %
91.30
91.30
Schrodinger Inc
SDGR
Schrodinger Inc
P/E Ratio
—
—
1Y Return
45.52%
45.52%
Buy Reco %
71.42
71.42
Inspire Medical Systems Inc
INSP
Inspire Medical Systems Inc
P/E Ratio
19.88
19.88
1Y Return
19.57%
19.57%
Buy Reco %
22.22
22.22
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

Higher price growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The 12-month consensus target implies 19.79% growth, versus a trailing 3-year CAGR of -44.55%.

2026
Current$4.8Baseline
Analyst Target - 1 year
Target$5.75+19.79%

All values in $

202220232024202520262027$11.78$19.97$28.15Target+19.79%
2026
Current$4.8Baseline
Analyst Target - 1 year
Target$5.75+19.79%

All values in $

Revenue Forecast

Revenue Forecast

Higher revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 40.46% growth, versus a trailing 3-year CAGR of 11.54%.

2025
Current$1.87Baseline
Forecast for Dec 2026
High$2.66+42.29%
Average$2.63+40.46%
Low$2.56+36.48%

All values in $ Billion

2021202220232024202520260.901.351.962.551.87Low+36.48%Average+40.46%High+42.29%
2025
Current$1.87Baseline
Forecast for Dec 2026
High$2.66+42.29%
Average$2.63+40.46%
Low$2.56+36.48%

All values in $ Billion

Earnings Per Share Forecast

Earnings Per Share Forecast

Higher earnings growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 899.50% growth, versus a trailing 3-year CAGR of -71.99%.

2025
Current$0.02Baseline
Forecast for Dec 2026
High$0.27+1246.5%
Average$0.2+899.5%
Low$0.1+400%

All values in $

2021202220232024202520260.020.910.880.660.02Low+400%Average+899.5%High+1246.5%
2025
Current$0.02Baseline
Forecast for Dec 2026
High$0.27+1246.5%
Average$0.2+899.5%
Low$0.1+400%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

479.5
-20.8
468.7
-429.1
496.2
-26.6
652.5
-28.3
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue639.65647.14621.40646.54483.64444.32479.53468.71496.24652.52
Net Income-17.281.59-23.13-22.80-64.61-19.89-20.86-429.13-26.63-28.36
Net Profit Margin-2.70%0.24%-3.72%-3.52%-13.36%-4.47%-4.35%-91.55%-5.36%-4.34%
See CostsAll values in $ Million

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareHealth Information Services

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Evolent Health Inc -1.261.92
Veeva Systems Inc Class A50.926.601.16
Doximity Inc40.786.340.58
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare EVH with any stock or ETF
Compare EVH with any stock or ETF
Comparing from
EVH
VEEV
DOCS
Loading...

Frequently asked questions

  1. Evolent Health Inc (EVH) share price today is $4.54 as of November 6, 2026 at 10:18 PM IST. The stock touched a day high of $4.81 and a day low of $4.42.

  2. Evolent Health Inc stock trades on NYSE under the ticker symbol EVH.

  3. Evolent Health Inc's market capitalization is $542.68M as of November 6, 2026 at 10:18 PM IST.

  4. Evolent Health Inc's price-to-earnings (P/E) ratio is N/A as of November 6, 2026.

  5. Evolent Health Inc's price-to-book (P/B) ratio is 1.26 as of November 6, 2026.

  6. Yes, You can buy Evolent Health Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Evolent Health Inc shares in three steps: 1. Search Evolent Health Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Evolent Health Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Evolent Health Inc (EVH) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 2.2002 shares at the current price of $4.54.

Loading...